Evidence map›Paper›PMID 26714808›Full record

ArticleAnnals of intensive care2015

Renal replacement therapy in adult and pediatric intensive care : Recommendations by an expert panel from the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) French Group for Pediatric Intensive Care Emergencies (GFRUP) the French Dialysis Society (SFD).

Christophe Vinsonneau, Emma Allain-Launay, Clarisse Blayau, Michael Darmon, Damien Ducheyron, Theophile Gaillot, Patrick M Honore, Etienne Javouhey, Thierry Krummel, Annie Lahoche and 11 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Annals of intensive care, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06369064 (Comparison of the Effectiveness of Continuous Veno-venous Hemodialysis and Continuous Veno-venous Hemodiafiltration on Urea Reduction Rate in Intensive Care Patients With Acute Renal Injury), which is not on this map. Cited by 54 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 5 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06369064 narecruitingnot on this mapstarted 2024, after this paper: background citation

Comparison of the Effectiveness of Continuous Veno-venous Hemodialysis and Continuous Veno-venous Hemodiafiltration on Urea Reduction Rate in Intensive Care Patients With Acute Renal Injury : a Monocentric Controled Randomized Non Inferiority Open Labeled Study

TypeinterventionalSponsorCentre Hospitalier Universitaire de NīmesRan2024 to 2028Enrolled80ConditionsAcute Kidney Injury, Continuous Renal Replacement Therapy, Intensive Care UnitArmsCVVHD Dialysis parameters, CVVHDF Dialysis parameters
3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 5 syntheses or guidelines pooled it, 152 citations in OpenAlex.

  1. Timing of kidney replacement therapy initiation for acute kidney injury.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Guideline
  3. Timing of renal replacement therapy initiation for acute kidney injury.The Cochrane database of systematic reviews · 2018
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Prognosis of Long-Term Continuous Renal Replacement Therapy and the Impact of Combined Continuous Intravenous Sodium Infusion Therapy.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2026
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Clinical effects of combination therapy with continuous renal replacement therapy and continuous intravenous sodium infusion therapy.Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 16 institutions in 2 countries.

Christophe VinsonneauRéanimation polyvalente, CH Melun, 77000, Melun, France. christophe.vinsonneau@ch-melun.fr.
Emma Allain-LaunayCHU Nantes, Nantes, France. emma.allainlaunay@chu-nantes.fr.
Clarisse BlayauCHU Tenon, 75020, Paris, France. clarisse.blayau@tnn.aphp.fr.
Michael DarmonCHU Saint-Etienne, 42055, Saint-Etienne, France. michael.darmon@chu-st-etienne.fr.
Damien DucheyronCHU Caen, 14033, Caen, France. ducheyron-d@chu-caen.fr.
Theophile GaillotCHU Rennes, 35000, Rennes, France. theophile.gaillot@chu-rennes.fr.
Patrick M HonoreIntensive Care Department, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium. patrick.honore@uzbrussel.be.
Etienne JavouheyRéanimation pédiatrique spécialisée, CHU Lyon, 69677, Bron, France. etienne.javouhey@chu-lyon.fr.
Thierry KrummelCHRU Strasbourg, Strasbourg, France. thierry.krummel@chru-strasbourg.fr.
Annie LahocheCHRU Lille, Lille, France. annie.lahoche@chru-lille.fr.
Serge LetaconCHU Nancy, Nancy, France. s.letacon@chu-nancy.fr.
Matthieu LegrandCHU Saint-Louis Lariboisière, Paris, France. matthieu.legrand@sls.aphp.fr.
Mehran MonchiRéanimation polyvalente, CH Melun, 77000, Melun, France. mn.monchi@gmail.com.
Christophe RidelCHU Tenon, 75020, Paris, France. christophe.ridel@gmail.com.
René RobertCHU Poitiers, Poitiers, France. rene.robert@chu-poitiers.fr.
Frederique SchortgenCHU Mondor, 94000, Créteil, France. frederique.schortgen@hmn.aphp.fr.
Bertrand SouweineCHU Clermont-Ferrand, Clermont-Ferrand, France. bsouweine@chu-clermontferrand.fr.
Patrick VaillantCHU Necker, 75000, Paris, France. patrick.vaillant@nck.aphp.fr.
Lionel VellyCHU Marseille, Marseille, France. lionel.velly@ap-hm.fr.
David OsmanCHU Bicêtre, 94, Le Kremlin Bicêtre, France. david.osman@bct.aphp.fr.
Ly Van VongRéanimation polyvalente, CH Melun, 77000, Melun, France. vong.lvp@free.fr.
Melun Hospital · FRSorbonne Université · FRBicêtre Hospital · FRCentre Hospitalier Régional et Universitaire de Nancy · FRCentre Hospitalier Universitaire de Caen · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRCentre Hospitalier Universitaire de Lille · FRCentre Hospitalier Universitaire de Nantes · FRCentre Hospitalier Universitaire de Poitiers · FRCentre Hospitalier Universitaire de Rennes · FRCentre Hospitalier Universitaire de Saint-Étienne · FRHôpital Lariboisière · FRHôpital Necker-Enfants Malades · FRHôpitaux Universitaires de Strasbourg · FRInstitut Mondor de Recherche Biomédicale · FRVrije Universiteit Brussel · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute renal failure (ARF) in critically ill patients is currently very frequent and requires renal replacement therapy (RRT) in many patients. During the last 15 years, several studies have considered important issues regarding the use of RRT in ARF, like the time to initiate the therapy, the dialysis dose, the types of catheter, the choice of technique, and anticoagulation. However, despite an abundant literature, conflicting results do not provide evidence on RRT implementation. We present herein recommendations for the use of RRT in adult and pediatric intensive care developed with the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system by an expert group of French Intensive Care Society (SRLF), with the participation of the French Society of Anesthesia and Intensive Care (SFAR), the French Group for Pediatric Intensive Care and Emergencies (GFRUP), and the French Dialysis Society (SFD). The recommendations cover 4 fields: criteria for RRT initiation, technical aspects (access routes, membranes, anticoagulation, reverse osmosis water), practical aspects (choice of the method, peritoneal dialysis, dialysis dose, adjustments), and safety (procedures and training, dialysis catheter management, extracorporeal circuit set-up). These recommendations have been designed on a practical point of view to provide guidance for intensivists in their daily practice.

Indexed as

AnticoagulationCitrateContinuous renal replacement therapyDialysis doseHemodialysisRecommendationsRenal replacement therapy

Identifiers

PMID26714808
PMCPMC4695466
OpenAlexW2211921164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.